Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2007 | 12-2006 | 09-2006 | 06-2006 | 03-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 277 | 561 | 756 | 999 | 1,089 |
| Receivables | 4 | N/A | 8 | 7 | 506 |
| TOTAL | $335 | $619 | $813 | $1,110 | $1,737 |
| Non-Current Assets | |||||
| PPE Net | 11 | 11 | 7 | 1 | 5 |
| Other Non-Current Assets | 21 | 21 | 23 | 29 | 21 |
| TOTAL | $32 | $32 | $30 | $30 | $26 |
| Total Assets | $367 | $651 | $843 | $1,141 | $1,762 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 553 | 432 | 315 | 279 | 297 |
| TOTAL | $839 | $616 | $498 | $461 | $438 |
| Non-Current Liabilities | |||||
| Long Term Debt | 672 | 632 | 594 | 558 | 524 |
| Deferred Revenues | 186 | 184 | 182 | 182 | 141 |
| Other Non-Current Liabilities | 11 | 0 | 9 | 8 | 7 |
| TOTAL | $1,900 | $1,900 | $1,902 | $1,904 | $1,949 |
| Total Liabilities | $2,739 | $2,516 | $2,400 | $2,365 | $2,387 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 22,834 | 22,574 | 22,574 | 22,574 | 22,574 |
| Common Shares | 40,494 | 40,447 | 40,377 | 40,369 | 40,302 |
| Retained earnings | -42,960 | -42,406 | -42,028 | -41,688 | -41,020 |
| TOTAL | $-2,373 | $-1,865 | $-1,557 | $-1,225 | $-624 |
| Total Liabilities And Equity | $367 | $651 | $843 | $1,141 | $1,762 |